![]() |
市場調查報告書
商品編碼
1416171
鼻插管市場 - 按類型、材料、應用、最終用途 - 全球預測,2023-2032 年Nasal Cannula Market - By Type, By Material, Application, End use - Global Forecast, 2023-2032 |
在呼吸系統疾病的流行、人口老化和技術進步的推動下,全球鼻插管市場預計將在 2023 年和 2032 年實現 6.2% 的成長率。
根據世界衛生組織2022年的報告,呼吸道感染佔全球疾病的6%,每年導致660萬五歲以下兒童死亡,其中三分之一歸因於低收入國家的急性呼吸道感染(ARIs)。老年人口的增加和呼吸系統疾病的激增正在推動對鼻插管作為補充氧氣的重要工具的需求。此外,人們越來越認知到該產品相對於傳統氧氣面罩的優勢,包括增強的舒適度和患者依從性,進一步加速了市場成長。設計和所用材料的技術進步將塑造行業軌跡,吸引醫療保健提供者和患者。
整個鼻插管產業根據類型、材料、應用、最終用途和地區進行分類。
由於其卓越的特性,包括靈活性、耐用性和生物相容性,矽膠鼻插管細分市場預計到 2032 年將實現前所未有的成長。它們提供舒適的貼合感,降低皮膚刺激的風險並提高患者滿意度。此外,該材料的靈活性可輕鬆適應患者的臉部輪廓,確保安全、舒適地貼合,以實現高效的氧氣輸送。
急性呼吸衰竭應用領域預計到 2032 年將實現良好成長。該產品用於為急性呼吸衰竭患者提供氧氣治療,促進及時介入和救生護理。隨著呼吸系統緊急情況發生率的上升以及對早期有效呼吸支持的日益重視,鼻插管將擴大整合到急性呼吸衰竭應用中,以實現快速有效的供氧。
由於呼吸照護解決方案需求激增、人口不斷成長、醫療基礎設施不斷完善以及呼吸系統疾病患病率不斷上升,亞太地區鼻插管市場規模預計將在 2023 年至 2032 年期間快速成長。中國和印度等國家處於這一成長的最前沿,人們對呼吸系統健康重要性的認知不斷提高,患者群體不斷擴大。市場參與者策略性地專注於擴大在亞太地區的業務,並利用該地區不斷發展的醫療保健領域中尚未開發的機會。
The global nasal cannula market is expected to register 6.2% growth rate over 2023 and 2032 fueled by the prevalence of respiratory disorders, ageing population, and technological advancements.
According to a report by WHO in 2022, respiratory infections, 6% of global diseases, cause 6.6 million annual deaths in under-five years old children, with one-third attributed to acute respiratory infections (ARIs) in low-income countries. The rising geriatric population and the associated surge in respiratory ailments are driving the demand for nasal cannulas as a vital tool for delivering supplemental oxygen. Additionally, the growing awareness of the product advantages over traditional oxygen masks, including enhanced comfort and patient compliance, is further accelerating market growth. The technological advancements in the design and materials used will shape the industry trajectory, attracting both healthcare providers and patients alike.
The overall nasal cannula industry is classified based on type, material, application, end-use and region.
The silicone nasal cannulas segment is set for unprecedented growth through 2032 owing to their superior characteristics, including flexibility, durability, and biocompatibility. They offer a comfortable fit, reducing the risk of skin irritation and enhancing patient satisfaction. Moreover, the material's flexibility allows for easy adaptation to the patient's facial contours, ensuring a secure and snug fit for efficient oxygen delivery.
The acute respiratory failure application segment is set for decent growth through 2032. The product is usage for delivering oxygen therapy to patients experiencing acute respiratory failure, facilitating prompt intervention and life-saving care. With the rising incidence of respiratory emergencies and the increasing emphasis on early & effective respiratory support, there will be increasing integration of nasal cannulas for the acute respiratory failure application for rapid and efficient oxygen administration.
Asia Pacific nasal cannula market size is poised for rapid growth during 2023-2032 driven by a surge in demand for respiratory care solutions, growing population, rising healthcare infrastructure, and an increasing prevalence of respiratory disorders. Countries like China and India are at the forefront of this growth, with a rising awareness of the importance of respiratory health and an expanding patient pool. Market players are strategically focusing on expanding their presence in the Asia Pacific region, capitalizing on the untapped opportunities in the region's evolving healthcare landscape.